I agree Our site saves small pieces of text information (cookies) on your device in order to deliver better content and for statistical purposes. You can disable the usage of cookies by changing the settings of your browser. By browsing our website without changing the browser settings you grant us permission to store that information on your device.
Meloxicam is developed for the treatment of rheumatoid arthritis and osteoarthritis. It is currently for the treatment of osteoarthritis and rheumatoid arthritis.
C Hawkey,; A Kahan,; K Steinbrück,; C Alegre,; E Baumelou,; B Bégaud,; J Dequeker,; H Isomäki,; G Littlejohn,; J Mau and S Papazoglou.Gastrointestinal tolerability of meloxicam compared to diclofenac in osteoarthritis patients. International MELISSA Study Group. Meloxicam Large-scale International Study Safety Assessment.. Rheumatology. 1998, 37(9), 937-945.
D. Türck,; W. Roth,; U. Busch. A Review of the Clinical Pharmacokinetics of Meloxicam. Rheumatology. 1996, 3513-16.
Gefahrenhinweise (EU): H302-H315-H319-H335
Harmful if swallowed. Causes skin irritation. Causes serious eye irritation. May cause respiratory irritation.
Avoid breathing dust/fume/gas/mist/vapours/spray. Wear protective gloves and eye/face protection. IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. IF INHALED: Remove to fresh air and keep at rest in a position comfortable for breathing. Store locked up. Dispose of contents/container in accordance with local/regional/national/international regulations.